InvestSMART

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) - Announcements

Current share price for NSB : $0.063 0.001 (1.56%)+

ASX company news and announcements for NeuroScientific Biopharmaceuticals Ltd (NSB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All NeuroScientific Biopharmaceuticals Ltd (NSB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than NeuroScientific Biopharmaceuticals Ltd (NSB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for NeuroScientific Biopharmaceuticals Ltd (NSB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 EmtinB Positive Results in MS 14 Jul 2020 8:21AM $0.200 $0.063 fallen by 68.50%
$25 Meet the CEOs Small Cap Webcast 10 Jun 2020 8:20AM $0.180 $0.063 fallen by 65%
$25 Techknow Invest Webinar Presentation 20 May 2020 9:37AM $0.185 $0.063 fallen by 65.95%
$25 Final Report received for Glaucoma Study 4 May 2020 10:01AM $0.185 $0.063 fallen by 65.95%
$25 Appendix 4C - quarterly 30 Apr 2020 1:57PM $0.195 $0.063 fallen by 67.69%
$25 NSB Signs Manufacturing Agreement with Mitsubishi 20 Apr 2020 8:55AM $0.180 $0.063 fallen by 65%
$25 Company Secretary Appointment/Resignation 20 Apr 2020 8:17AM $0.180 $0.063 fallen by 65%
$25 Positive Results in MS Study 18 Mar 2020 9:29AM $0.145 $0.063 fallen by 56.55%
$25 Trading Halt 16 Mar 2020 9:09AM $0.145 $0.063 fallen by 56.55%
$25 Positive Results in Glaucoma Pig Model 11 Mar 2020 10:11AM $0.155 $0.063 fallen by 59.35%
$25 Trading Halt 9 Mar 2020 9:41AM $0.155 $0.063 fallen by 59.35%
$25 Half Yearly Report and Accounts 27 Feb 2020 7:07PM $0.165 $0.063 fallen by 61.82%
$25 NSB - Glaucoma Study Update 3 Feb 2020 8:14AM $0.170 $0.063 fallen by 62.94%
$25 Appendix 4C - quarterly 31 Jan 2020 12:14PM $0.170 $0.063 fallen by 62.94%
$25 Additional US Patent granted 22 Jan 2020 8:23AM $0.165 $0.063 fallen by 61.82%
$25 NSB - Glaucoma Study Update 24 Dec 2019 8:18AM $0.190 $0.063 fallen by 66.84%
$25 Appendix 3B 17 Dec 2019 8:25PM $0.200 $0.063 fallen by 68.50%
$25 Appendix 4G 17 Dec 2019 8:24PM $0.200 $0.063 fallen by 68.50%
$25 CVN Model Indicates Neuroprotective Properties of EmtinB 6 Dec 2019 8:17AM $0.295 $0.063 fallen by 78.64%
$25 NSB - Company Update 2 Dec 2019 8:24AM $0.275 $0.063 fallen by 77.09%
$25 Results of AGM 29 Nov 2019 8:13PM $0.275 $0.063 fallen by 77.09%
$25 AGM Address 29 Nov 2019 8:18AM $0.300 $0.063 fallen by 79%
$25 NSB Presentation Nov 2019 19 Nov 2019 10:27AM $0.235 $0.063 fallen by 73.19%
$25 NSB - Company Update 18 Nov 2019 8:13AM $0.225 $0.063 fallen by 72%
$25 Appendix 3B - Options Exercised 1 Nov 2019 8:09AM $0.230 $0.063 fallen by 72.61%

301 - 325 of 406 results

Page 13 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.